113 related articles for article (PubMed ID: 12860197)
1. Effect of long-term CCK blockade on the pancreatic acinar cell renewal in rats with acute pancreatitis.
de la Mano AM; Sevillano S; Manso MA; de Dios I
Peptides; 2003 Apr; 24(4):535-41. PubMed ID: 12860197
[TBL] [Abstract][Full Text] [Related]
2. Effects of early decompression and cholecystokinin inhibition in rats with acute pancreatitis induced by bile-pancreatic-duct obstruction.
de Dios I; Urunuela A; Manso M
J Lab Clin Med; 2003 Apr; 141(4):265-71. PubMed ID: 12677172
[TBL] [Abstract][Full Text] [Related]
3. Cholecystokinin blockade triggers earlier and enhanced intra-acinar oxygen free radical generation in acute pancreatitis induced by pancreatic duct obstruction in rats.
Uruñuela A; Manso MA; de la Mano AM; de Dios I
Clin Sci (Lond); 2003 Aug; 105(2):203-12. PubMed ID: 12713440
[TBL] [Abstract][Full Text] [Related]
4. Cholecystokinin antagonist L364,718 induces alterations in acinar cells that prevent improvement of acute pancreatitis induced by obstruction.
De Dios I; Uruñuela A; Orfao A; Manso MA
Dig Dis Sci; 2002 Aug; 47(8):1800-9. PubMed ID: 12184533
[TBL] [Abstract][Full Text] [Related]
5. Low enzyme content in the pancreas does not reduce the severity of acute pancreatitis induced by bile-pancreatic duct obstruction.
De La Mano A; Sevillano S; De Dios I; Vicente S; Manso MA
Mol Cell Biochem; 2002 Nov; 240(1-2):75-81. PubMed ID: 12487374
[TBL] [Abstract][Full Text] [Related]
6. Cholecystokinin blockade alters the systemic immune response in rats with acute pancreatitis.
de la Mano AM; Sevillano S; Manso MA; Pérez M; de Dios I
Int J Exp Pathol; 2004 Apr; 85(2):75-84. PubMed ID: 15154913
[TBL] [Abstract][Full Text] [Related]
7. Kinetic study of TNF-alpha production and its regulatory mechanisms in acinar cells during acute pancreatitis induced by bile-pancreatic duct obstruction.
Ramudo L; Manso MA; Sevillano S; de Dios I
J Pathol; 2005 May; 206(1):9-16. PubMed ID: 15761843
[TBL] [Abstract][Full Text] [Related]
8. Octreotide and cholecystokinin antagonist reduce edema in obstruction-induced acute pancreatitis.
Toriumi Y; Samuel I; Wilcockson DP; Turkelson CM; Solomon TE; Joehl RJ
J Lab Clin Med; 1993 Oct; 122(4):450-4. PubMed ID: 8228560
[TBL] [Abstract][Full Text] [Related]
9. Pro- and anti-inflammatory response of acinar cells during acute pancreatitis. Effect of N-acetyl cysteine.
Ramudo L; Manso MA; Vicente S; De Dios I
Cytokine; 2005 Nov; 32(3-4):125-31. PubMed ID: 16263306
[TBL] [Abstract][Full Text] [Related]
10. Long-term blockade of cholecystokinin (CCK): effects of L 364,718 (a CCK receptor antagonist) on pancreatic enzyme storage and secretion.
Rodriguez AI; Manso MA; Garcia-Montero AC; Orfao A; de Dios I
Pancreas; 1997 Oct; 15(3):314-22. PubMed ID: 9336798
[TBL] [Abstract][Full Text] [Related]
11. Involvement of endogenous cholecystokinin in pancreatic regeneration after cerulein-induced acute pancreatitis.
Jurkowska G; Grondin G; Morisset J
Pancreas; 1992; 7(3):295-304. PubMed ID: 1594550
[TBL] [Abstract][Full Text] [Related]
12. Effects of the cholecystokinin A receptor antagonist loxiglumide on the proliferation and cell cycle time of pancreatic acinar cells in rats.
Kanemitsu D; Sakagami J; Motoyoshi T; Nakajima T; Kataoka K
Pancreas; 2006 Mar; 32(2):190-6. PubMed ID: 16552340
[TBL] [Abstract][Full Text] [Related]
13. Effect of endogenous cholecystokinin on the course of acute pancreatitis in rats.
Jia D; Yamamoto M; Otsuki M
World J Gastroenterol; 2015 Jul; 21(25):7742-53. PubMed ID: 26167074
[TBL] [Abstract][Full Text] [Related]
14. N-acetylcysteine induces beneficial changes in the acinar cell cycle progression in the course of acute pancreatitis.
Sevillano S; de Dios I; de la Mano AM; Manso MA
Cell Prolif; 2003 Oct; 36(5):279-89. PubMed ID: 14521521
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a new CCK antagonist, L364,718: in vitro and in vivo studies.
Louie DS; Liang JP; Owyang C
Am J Physiol; 1988 Sep; 255(3 Pt 1):G261-6. PubMed ID: 2458681
[TBL] [Abstract][Full Text] [Related]
16. Do cholecystokinin antagonists increase cytosolic calcium in pancreatic acinar cells and thereby promote pancreatitis?
Niederau C
Dig Dis Sci; 2004 Feb; 49(2):266-9. PubMed ID: 15104368
[TBL] [Abstract][Full Text] [Related]
17. Benzodiazepine analogues L365,260 and L364,718 as gastrin and pancreatic CCK receptor antagonists.
Huang SC; Zhang L; Chiang HC; Wank SA; Maton PN; Gardner JD; Jensen RT
Am J Physiol; 1989 Jul; 257(1 Pt 1):G169-74. PubMed ID: 2473653
[TBL] [Abstract][Full Text] [Related]
18. Cholecystokinin augmentation of 'surgical' pancreatitis. Benefits of receptor blockade.
Modlin IM; Bilchik AJ; Zucker KA; Adrian TE; Sussman J; Graham SM
Arch Surg; 1989 May; 124(5):574-8. PubMed ID: 2469410
[TBL] [Abstract][Full Text] [Related]
19. Cholecystokinin acts as an essential factor in the exacerbation of pancreatic bile duct ligation-induced rat pancreatitis model under non-fasting condition.
Yoshinaga K; Washizuka M; Segawa Y
Jpn J Pharmacol; 2000 Sep; 84(1):44-50. PubMed ID: 11043452
[TBL] [Abstract][Full Text] [Related]
20. Effects of the specific cholecystokinin antagonist L 364,718 in experimental acute pancreatitis in the rat.
Sjövall S; Ahrén B; Stenram U
Eur Surg Res; 1988; 20(5-6):325-9. PubMed ID: 2465158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
